Aim: To analyze role of Glucosamine sulphate supplements given for treatment of Osteoarthritis on intraocular pressure. Materials & Methods: A case series of 100 patients who were diagnosed to have Osteoarthritis were selected and started on Glucosamine sulphate supplements in whom IOP was measured and analyzed for 1 year (From March 2017-March 2018 in GIMSR Results: Out of 111 patients selected for study,11 patients were excluded as they were having high IOP, glaucomatous changes in fundus , corneal irregularities and postoperative cases  Out of 100 patients 78 were females and 22 were males  Most common age group being 40 to 60 years in both males and females  IOP changes were more common in females than males  IOP rise of 2mm Hg was identified in both eyes after a period of 1 year in considerable no of patients Conclusions: Out of total number of 20,000 patients attended Orthopaedics department from March 2017 to March 2018 in GIMSR, 5000 patients complained of kneeproblem. Among them 100 patients were selected for the study. Patients with previous history of glaucoma, previous surgeries, fundus changes, not willing for regular follow up and corneal abnormalities were excluded from the study. Measurement of IOP was done in all 100 patients before starting of Glucosamine sulphate and patients were instructed to come for regular follow-ups 5 times at 3 months interval.
Introduction
An amino monosaccharide Glucosamine is an essential constituent of cartilage. Glucosamine sulphate supplements widely used for Osteoarthritis treatment appear to increase IOP, researchers say. Though evidence is lacking that it can improve symptoms of Osteoarthritis, radiographic studies have shown that it slows joint space width loss and hence appears to be safe & popular as a treatment. However Glucosamine is also abundant in corneal stroma and plays a role in morphology and function of the trabecular meshwork. One small retrospective study showed an association between Glucosamine supplement usage and IOP. Glycosaminoglycans constitute ground substance for outermost part of the trabecular meshwork. Long, flexible chains of GAG interact with each otherto form a system of entangled polyanionic macromolecules which act like a gel and contribute to outflow resistance. Accumulated GAG in ground substance of trabecular meshwork outflow pathways and increased constriction of the trabecular spaces could explain rise in IOP seen with even short courses of steroid treatment. In this study our aim was to study role of Glucosamine supplements in Osteoarthritis patients on IOP among patients attending Orthopaedics department in GIMSR. This is a prospective study conducted over a period of 1 year from March 2017 to March 2018. These patients were kept on 750 mg Glucosamine sulphate supplements thrice a day and were referred to Ophthalmology department. Each patient was evaluated fully and IOP was measured in 5 consecutive visits :On the day of starting treatment, 3 months ,6months, 9months and 1year duration. Patients were counselled regarding usage of drug and necessity of review visits. So whoever willing to come for 5 follow ups were taken and IOP measurement was done using Goldmann applanation tonometry.
Aims & Objectives
To find out role of Glucosamine sulphate supplements given in Osteoarthritis patients on IOP attending outpatient Orthopaedics and Ophthalmology departments in GIMSR
Materials & Methods
This is a prospective study conducted over a period of one year from March 2017 to March 2018 in GIMSR Out of all patients attending Orthopedics department with osteoarthritis, 111 patients were selected and started on Glucosamine sulphate 750 mg thrice a day and were sent to Ophthalmology department for evaluation before starting treatment .The patients were asked for follow up in 5 consecutive visits. Patients already diagnosed with more IOP and fundus changes were excluded and 100 patients were selected finally for study. Out of 100 patients selected for the study 78 were females (78%) and 22 were males (22%) Table 1 : shows sex distribution in the study revealing females were more effected than males  In our study major proportion of patients were females constituting78% compared to males who were only 22%.  Commonest age group effected both in males and females was 40-60 years .  Normal range of 10 to 20 mm Hg IOP was seen in almost 90% of the patients  After administration of drug for a period of 3 months not much IOP change was noticed  After 6 months 34% of patients have shown 2 mm Hg increase in IOP but were within the normal range  Thus glucosamine sulphate can be used in Osteoarthritis with regular monitoring of IOP and considered to be relatively safe.
Inclusion Criteria

